Rarecells

Paris, France

Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.

$5.0M raised

Dec 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Rarecells raised?

Rarecells has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Who are Rarecells's investors?

Rarecells's investors include Globivest, AA Sons.

Where is Rarecells headquartered?

Rarecells is headquartered in Paris, France.

What does Rarecells do?

Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.

What stage is Rarecells at?

Rarecells is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 9, 2021.

MLA

"Rarecells — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/rarecells. Accessed July 10, 2026.

APA

VCBacked. (2021). Rarecells — Funding & Investors. Retrieved July 10, 2026, from https://www.vcbacked.co/company/rarecells

Wikipedia (cite web)

{{cite web |title=Rarecells — Funding & Investors |url=https://www.vcbacked.co/company/rarecells |website=VCBacked |access-date=July 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 9, 2021.